Montelukast Synthon 4 mg Kautabletten Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

montelukast synthon 4 mg kautabletten

synthon b.v. (8010015) - montelukast-natrium - kautablette - teil 1 - kautablette; montelukast-natrium (27913) 4,16 milligramm

Prezista European Union - German - EMA (European Medicines Agency)

prezista

janssen-cilag international nv - darunavir - hiv-infektionen - antivirale mittel zur systemischen anwendung - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.

Cosduo 20 mg/ml + 5 mg/ml, Augentropfen, Lösung Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

cosduo 20 mg/ml + 5 mg/ml, augentropfen, lösung

santen oy (3332582) - dorzolamidhydrochlorid; timololmaleat - augentropfen, lösung - teil 1 - augentropfen, lösung; dorzolamidhydrochlorid (26539) 22,26 milligramm; timololmaleat (12113) 6,83 milligramm

Topirafinelin 100 mg Filmtabletten Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

topirafinelin 100 mg filmtabletten

alchemia limited (8084634) - topiramat - filmtablette - topiramat (24994) 100 milligramm

Topirafinelin 200 mg Filmtabletten Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

topirafinelin 200 mg filmtabletten

alchemia limited (8084634) - topiramat - filmtablette - topiramat (24994) 200 milligramm

Topirafinelin 50 mg Filmtabletten Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

topirafinelin 50 mg filmtabletten

alchemia limited (8084634) - topiramat - filmtablette - topiramat (24994) 50 milligramm

Eurovinorelbin 10 mg/ml Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

eurovinorelbin 10 mg/ml

lapharm gmbh pharmazeutische produkte (8151862) - vinorelbinbis[(r,r)-tartrat] - konzentrat zur herstellung einer infusionslösung - teil 1 - konzentrat zur herstellung einer infusionslösung; vinorelbinbis[(r,r)-tartrat] (26063) 13,85 milligramm

Salofalk Granu-Stix 1000 mg magensaftresistentes Retardgranulat Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

salofalk granu-stix 1000 mg magensaftresistentes retardgranulat

dr. falk pharma gmbh (3076297) - mesalazin - magensaftresistentes retardgranulat - mesalazin (21958) 1000 milligramm

Salofalk Granu-Stix 500 mg magensaftresistentes Retardgranulat Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

salofalk granu-stix 500 mg magensaftresistentes retardgranulat

dr. falk pharma gmbh (3076297) - mesalazin - magensaftresistentes retardgranulat - mesalazin (21958) 500 milligramm

Navirel 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

navirel 10 mg/ml konzentrat zur herstellung einer infusionslösung

medac gesellschaft für klinische spezialpräparate m.b.h. (3083854) - vinorelbinbis[(r,r)-tartrat] - konzentrat zur herstellung einer infusionslösung - teil 1 - konzentrat zur herstellung einer infusionslösung; vinorelbinbis[(r,r)-tartrat] (26063) 13,85 milligramm